The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…
Read More
Novo Nordisk Drops Nordisk in Major Rebrand to Modernise Identity Amid Fierce Competition in Obesity and Diabetes Markets
The pharmaceutical landscape is undergoing a quiet yet profound visual and strategic evolution, and one of its most prominent titans…
Read More
Pressure Intensifies on Novartis as Bolt-On Deal Strategy Faces Major Test
Swiss pharmaceutical giant Novartis is facing a defining moment in its corporate history as its heavy reliance on bolt-on acquisitions…
Read More
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Solstice Oncology has successfully closed a landmark $225 million Series A funding round to accelerate the clinical development of its…
Read More
ABEC Expands US Biomanufacturing Footprint With New Wilson, North Carolina Facility
The global biotechnology and pharmaceutical engineering sector is witnessing a significant infrastructural expansion as ABEC prepares to officially open its…
Read More
Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy
In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…
Read More
Biotech Competition Spurs New Secretive Tactics and Shifts Investor Approach
The global biotechnology sector is undergoing a profound cultural and strategic transformation, driven by an increasingly cutthroat competitive landscape that…
Read More
ERS 2026 Insights: Body Mass Index and Type 2 Inflammation as Major Predictors of Asthma Attack Risk
Respiratory medicine continues to evolve as researchers uncover complex interactions between metabolic health, systemic inflammation, and chronic airway diseases. Among…
Read More
UK Health Watchdog Drafts Against Routine NHS Funding for Gilead’s Twice-Yearly HIV Prevention Injection Lenacapavir
The National Institute for Health and Care Excellence (NICE) has issued a preliminary recommendation against the routine NHS commissioning of…
Read More
HHS Appoints Four Permanent Senior Leaders to Stabilize and Reform the US Food and Drug Administration Amid Leadership Turmoil
The US Department of Health and Human Services (HHS) has announced the appointment of four permanent senior leaders to critical…
Read More
